Vivaldi Coelho Rogerio Insider Trades

Insider Trading History

Track insider trading activity for Vivaldi Coelho Rogerio. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $1.86M 22,225 shares
Last Trade
Jun 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$562k 15,655 shares
$35.87
$83.90
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $1.41M 16,823 shares
Last Trade
Mar 12, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$181k 5,000 shares
$36.15
$83.90
Viatris
Viatris VTRS
Director
Holding Value $776k 46,526 shares
Last Trade
Mar 06, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$352k 24,835 shares
$14.16
$16.68
Viatris
Viatris VTRS
Director
Holding Value $265k 15,890 shares
Last Trade
Mar 06, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$225k 15,890 shares
$14.16
$16.68
Viatris
Viatris VTRS
Director
Holding Value $0 0 shares
Last Trade
Mar 06, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$352k 24,834 shares
$14.16
$16.68
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $1.79M 21,300 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$335k 10,350 shares
$32.33
$83.90
Viatris
Viatris VTRS
Director
Holding Value $395k 23,660 shares
Last Trade
Mar 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$225k 23,660 shares
$9.51
$16.68
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $1.21M 14,400 shares
Last Trade
Jun 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$559k 12,500 shares
$44.71
$83.90
Viatris
Viatris VTRS
Director
Holding Value $355k 21,267 shares
Last Trade
Jun 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$225k 21,267 shares
$10.58
$16.68
Sigilon Therapeutics
Sigilon Therapeutics SGTX
PRESIDENT AND CEO
Holding Value $0 0 shares
Last Trade
Aug 11, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.07M 47,551 shares
$22.47
$22.47
Sigilon Therapeutics
Sigilon Therapeutics SGTX
PRESIDENT AND CEO
Holding Value $273k 12,163 shares
Last Trade
Jul 21, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$106k 5,528 shares
$19.24
$22.47
Sigilon Therapeutics
Sigilon Therapeutics SGTX
PRESIDENT AND CEO
Holding Value $269k 11,963 shares
Last Trade
Jul 21, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$106k 5,528 shares
$19.24
$22.47
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $1.47M 17,500 shares
Last Trade
Jun 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$356k 17,500 shares
$20.32
$83.90
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $420k 5,000 shares
Last Trade
Jun 08, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$110k 5,000 shares
$22.06
$83.90
Sigilon Therapeutics
Sigilon Therapeutics SGTX
PRESIDENT AND CEO
Holding Value $10.3M 460,000 shares
Last Trade
Feb 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$84.7M 460,000 shares
$184.21
$22.47
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $734k 8,750 shares
Last Trade
Jun 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$160k 8,750 shares
$18.29
$83.90
Sigilon Therapeutics
Sigilon Therapeutics SGTX
PRESIDENT AND CEO
Holding Value $5.17M 230,000 shares
Last Trade
Feb 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$57.5M 230,000 shares
$250.12
$22.47
Sigilon Therapeutics
Sigilon Therapeutics SGTX
PRESIDENT AND CEO
Holding Value $8.99M 400,000 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$205M 400,000 shares
$512.07
$22.47
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $2.94M 35,000 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$991k 35,000 shares
$28.31
$83.90
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $2.1M 25,000 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$708k 25,000 shares
$28.31
$83.90

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up